← SynDRA
AMINOLEVULINIC ACID
SynDRA canonical compound SYN0001060 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ALAD |
| Mechanism of action | oxidizing agent |
| Indication | actinic keratosis (AK) | glioma |
| Disease area | dermatology | oncology |
All known targets
Mechanisms of action (all sources)
- oxidizing agent
- ALAD INHIBITOR
- PPOX MODULATOR
Drug classes
- Dermatologic Agents
- Photosensitizing Agents
- Radiation-Sensitizing Agents
- Porphyrin Precursor
- Fluorescence Contrast Activity
- Optical Imaging Agent
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- ameluz
- 5-amino-4-oxopentanoic acid
- aladerm
- alasens
- 5-aminolevulinic acid
- 5-aminolevulinic acid hydrochloride
- Gliolan
- aminolevulinic acid hydrochloride
- 5-aminolevulinic acid HCl
- aminolevulinic acid HCl
- .delta.-aminolevulinic acid
- Aminolevulinic Acid Hydrochloride
- Levulan
- Levulan Kerastick
- Aminolevulinic acid hci
- 5-Aminolevulinic acid
- 5-Amino-4-oxopentanoic acid
- 5-Aminolevulinate
- delta-aminolevulinic acid
- Pentanoic acid, 5-amino-4-oxo-
- Aladerm
- 5-Amino-4-oxovaleric acid
- Kerastick
- Ameluz
- Aminolevulinate
- 5-ALA
- delta-ALA
- 5-Amino-4-oxopentanoate
- 5-amino-levulinate
- 5-amino-levulinic acid
- 5-amino-4-oxo-pentanoic acid
- CCRIS 8958
- UNII-88755TAZ87
- EINECS 203-414-1
- Levulinic acid, 5-amino-
- CHEMBL601
- 4-oxo-5-amino-pentanoic acid
- CHEBI:17549
Reported adverse events
- Erythema
- Pustule
- Pain
- Discomfort
- Hypersensitivity
- Pruritus
- Scab
- Skin disorder
- Tenderness
- Induration
Look up AMINOLEVULINIC ACID in the interactive SynDRA portal →